Avantium NV (XAMS:AVTX) Other Stockholders Equity: €1.34 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XAMS:AVTX Avantium NV XAMS:AVTX
64 GF Score
Price €7.09
GF Value €6.11
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Avantium NV Other Stockholders Equity?

Avantium NV XAMS:AVTX 64 Other Stockholders Equity is €1.34 Mil as of Dec. 2025. GuruFocus rates XAMS:AVTX with a GF Score™ of 64/100 and a GF Value™ of €6.11 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Avantium NV's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €1.34 Mil.

Avantium NV's quarterly Other Stockholders Equity declined from Dec. 2024 (€8.39 Mil) to Jun. 2025 (€3.65 Mil) and declined from Jun. 2025 (€3.65 Mil) to Dec. 2025 (€1.34 Mil).

Avantium NV's annual Other Stockholders Equity increased from Dec. 2023 (€6.92 Mil) to Dec. 2024 (€8.39 Mil) but then declined from Dec. 2024 (€8.39 Mil) to Dec. 2025 (€1.34 Mil).

Avantium NV Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Avantium NV's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avantium NV Other Stockholders Equity Chart

Avantium NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.94 12.79 6.92 8.39 1.34

Avantium NV Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.92 7.29 8.39 3.65 1.34
XAMS:AVTX
64GF Score
Avantium NV XAMS:AVTX
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avantium NV Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €1.34 Mil mean?
Avantium NV (XAMS:AVTX) has a Other Stockholders Equity of €1.34 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Avantium NV and its competitors.
Is Avantium NV's Other Stockholders Equity too high?
Avantium NV's current Other Stockholders Equity is €1.34 Mil. Overall, Avantium NV has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avantium NV's Other Stockholders Equity compare to LIN and SHW?
Avantium NV's Other Stockholders Equity of €1.34 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Chemicals company?
A good Other Stockholders Equity depends on the Chemicals industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Avantium NV and its competitors. Avantium NV's current Other Stockholders Equity is €1.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantium NV stock overvalued right now?
Based on GuruFocus' analysis, Avantium NV (XAMS:AVTX) is currently considered Modestly Overvalued. The stock's GF Value™ is €6.11, compared to a current price of €7.09 — trading 16% above its estimated fair value. The current Other Stockholders Equity is €1.34 Mil. Avantium NV's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Avantium NV (XAMS:AVTX), the current Other Stockholders Equity is €1.34 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avantium NV (XAMS:AVTX) Overvalued in 2026?

Based on GuruFocus' analysis, Avantium NV stock appears to be overvalued. The current stock price of €7.09 is trading 16% above its estimated GF Value™ of €6.11. GuruFocus considers Avantium NV to be Modestly Overvalued.

Key valuation signals for XAMS:AVTX:

  • Other Stockholders Equity: €1.34 Mil
  • GF Value™: €6.11 vs. price of €7.09 (16% above fair value)
  • GF Score™: 64/100 with 8 warning signs

No single metric tells the full story. See the XAMS:AVTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Avantium NV Business Description

Address Zekeringstraat 29, Amsterdam, NLD, 1014 BV
Avantium NV along with its subsidiaries is engaged in developing and commercializing next-generation bio-based plastics and chemicals based on its technological capabilities in catalysis research and development. Avantium also provides solutions in the field of sustainable chemistry and provider of catalyst testing technology. The company operates through segments: R&D Solutions, and Renewable Polymer segments. The company generates the majority of its revenue from the R&D Solutions segment. R&D Solutions provides R&D solutions in the field of sustainable chemistry and is the provider of advanced catalyst testing technology and services to accelerate catalyst R&D. The company's products include: PEF & FDCA; CO2-based polyesters & chemicals; PlantMEG & PlantMPG; and R&D Solutions.
64GF Score

Get the complete analysis for XAMS:AVTX

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.09
Price
€6.11
GF Value